Welcome to our dedicated page for Atlantis Glory SEC filings (Ticker: AGLY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Atlantis Glory's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Atlantis Glory's regulatory disclosures and financial reporting.
Atlantis Glory Inc. (AGLY) filed its Q3 2025 report, showing no operating revenues and a small operating footprint focused on maintaining reporting status while seeking a business combination.
For the three months ended September 30, 2025, the company reported a net loss of $7,675. For the nine months ended September 30, 2025, the net loss was $23,854, driven by general and administrative expenses. Cash and cash equivalents were $0 as of September 30, 2025. Current liabilities totaled $195,283, including $187,333 of in‑demand loans from a related party. The accumulated deficit was $1,131,062. Management disclosed substantial doubt about the company’s ability to continue as a going concern.
Operating cash outflows for the nine months were $26,304, fully offset by related‑party financing of $26,304. The company remains dormant with no revenue and intends to pursue a reverse merger or similar transaction. Internal controls over financial reporting were deemed not effective due to limited personnel, lack of an independent board/audit committee, and absent written procedures. Common shares outstanding were 603,970,000 as of October 24, 2025.
